Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fat Emulsions, Intravenous | 58 | 2023 | 321 | 16.630 |
Why?
|
Fish Oils | 57 | 2023 | 470 | 15.200 |
Why?
|
Parenteral Nutrition | 68 | 2024 | 650 | 15.100 |
Why?
|
Cholestasis | 26 | 2023 | 378 | 8.280 |
Why?
|
Intestinal Diseases | 25 | 2024 | 530 | 8.140 |
Why?
|
Soybean Oil | 33 | 2023 | 133 | 7.900 |
Why?
|
Liver Diseases | 31 | 2024 | 1253 | 6.810 |
Why?
|
Short Bowel Syndrome | 22 | 2024 | 345 | 6.240 |
Why?
|
Fatty Acids, Essential | 17 | 2018 | 95 | 4.280 |
Why?
|
Fatty Acids, Omega-3 | 25 | 2019 | 1344 | 4.120 |
Why?
|
Liver Failure | 8 | 2024 | 241 | 4.060 |
Why?
|
Fatty Liver | 15 | 2023 | 727 | 3.260 |
Why?
|
Heparin | 6 | 2023 | 1637 | 2.580 |
Why?
|
Bilirubin | 12 | 2023 | 425 | 2.260 |
Why?
|
Vascular Endothelial Growth Factor A | 14 | 2023 | 3508 | 2.180 |
Why?
|
Dietary Fats | 14 | 2019 | 2017 | 2.140 |
Why?
|
Catheter-Related Infections | 7 | 2023 | 252 | 2.110 |
Why?
|
Docosahexaenoic Acids | 12 | 2017 | 875 | 2.090 |
Why?
|
Lung | 19 | 2024 | 9856 | 1.980 |
Why?
|
Pneumonectomy | 11 | 2023 | 1094 | 1.810 |
Why?
|
Liver | 32 | 2023 | 7474 | 1.780 |
Why?
|
Triglycerides | 20 | 2023 | 2454 | 1.780 |
Why?
|
Catheterization, Central Venous | 4 | 2023 | 514 | 1.640 |
Why?
|
Enteral Nutrition | 13 | 2023 | 763 | 1.580 |
Why?
|
Pyrroles | 6 | 2013 | 1146 | 1.520 |
Why?
|
Parenteral Nutrition, Total | 6 | 2020 | 302 | 1.510 |
Why?
|
Antithrombins | 2 | 2023 | 304 | 1.470 |
Why?
|
Mice, Inbred C57BL | 46 | 2023 | 21827 | 1.460 |
Why?
|
Tissue Adhesions | 5 | 2012 | 235 | 1.460 |
Why?
|
Arachidonic Acid | 7 | 2017 | 434 | 1.450 |
Why?
|
Isoquinolines | 2 | 2021 | 367 | 1.370 |
Why?
|
Fatty Acids | 13 | 2023 | 1809 | 1.340 |
Why?
|
Indoles | 7 | 2013 | 1839 | 1.340 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 8 | 2020 | 546 | 1.250 |
Why?
|
Protective Agents | 2 | 2019 | 156 | 1.250 |
Why?
|
Receptors, G-Protein-Coupled | 5 | 2020 | 1222 | 1.240 |
Why?
|
Disease Models, Animal | 37 | 2023 | 18029 | 1.210 |
Why?
|
Glycine | 2 | 2021 | 671 | 1.210 |
Why?
|
Hydroxamic Acids | 5 | 2011 | 494 | 1.200 |
Why?
|
Intestines | 12 | 2024 | 1924 | 1.190 |
Why?
|
Animals | 113 | 2024 | 168757 | 1.180 |
Why?
|
Swine | 10 | 2024 | 5917 | 1.140 |
Why?
|
Endotoxemia | 2 | 2019 | 207 | 1.120 |
Why?
|
Endothelial Cells | 11 | 2023 | 3479 | 1.050 |
Why?
|
Intestine, Small | 4 | 2023 | 1241 | 1.030 |
Why?
|
Reperfusion Injury | 3 | 2019 | 1026 | 1.030 |
Why?
|
Mice | 65 | 2024 | 81183 | 1.010 |
Why?
|
Malabsorption Syndromes | 4 | 2019 | 135 | 1.000 |
Why?
|
Intestinal Volvulus | 3 | 2023 | 65 | 0.990 |
Why?
|
Growth | 3 | 2020 | 376 | 0.990 |
Why?
|
Lipopolysaccharides | 4 | 2022 | 2216 | 0.990 |
Why?
|
alpha-Tocopherol | 3 | 2019 | 127 | 0.940 |
Why?
|
Dietary Supplements | 11 | 2017 | 3297 | 0.930 |
Why?
|
Parenteral Nutrition, Home | 2 | 2021 | 35 | 0.930 |
Why?
|
Pipecolic Acids | 1 | 2023 | 76 | 0.910 |
Why?
|
Fatty Acids, Omega-6 | 5 | 2013 | 227 | 0.910 |
Why?
|
Bacteremia | 4 | 2023 | 962 | 0.910 |
Why?
|
Infant, Newborn | 31 | 2023 | 25625 | 0.900 |
Why?
|
Infant | 39 | 2022 | 35136 | 0.880 |
Why?
|
Serpins | 2 | 2021 | 247 | 0.870 |
Why?
|
Protease Inhibitors | 3 | 2011 | 791 | 0.850 |
Why?
|
Alanine Transaminase | 9 | 2019 | 592 | 0.840 |
Why?
|
Phospholipids | 8 | 2013 | 784 | 0.830 |
Why?
|
Liver Regeneration | 7 | 2013 | 210 | 0.820 |
Why?
|
Acute Lung Injury | 2 | 2023 | 380 | 0.810 |
Why?
|
Emulsions | 7 | 2023 | 156 | 0.810 |
Why?
|
Arginine | 2 | 2023 | 944 | 0.800 |
Why?
|
Nerve Growth Factors | 2 | 2021 | 574 | 0.790 |
Why?
|
Lipids | 5 | 2017 | 3305 | 0.770 |
Why?
|
Eye Proteins | 2 | 2021 | 646 | 0.760 |
Why?
|
Parenteral Nutrition Solutions | 3 | 2015 | 27 | 0.750 |
Why?
|
Intestinal Neoplasms | 1 | 2023 | 319 | 0.740 |
Why?
|
Models, Animal | 4 | 2017 | 2171 | 0.730 |
Why?
|
Digestive System Surgical Procedures | 3 | 2023 | 576 | 0.730 |
Why?
|
PPAR gamma | 2 | 2023 | 493 | 0.720 |
Why?
|
Pulmonary Alveoli | 3 | 2020 | 675 | 0.700 |
Why?
|
Angiogenesis Inhibitors | 7 | 2013 | 2038 | 0.690 |
Why?
|
Linoleic Acid | 4 | 2024 | 157 | 0.690 |
Why?
|
Liver Cirrhosis | 5 | 2015 | 1863 | 0.690 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2017 | 347 | 0.650 |
Why?
|
Male | 86 | 2023 | 350118 | 0.630 |
Why?
|
Interleukin-6 | 8 | 2023 | 3200 | 0.610 |
Why?
|
Epithelial Cells | 2 | 2021 | 3690 | 0.610 |
Why?
|
Sulfonamides | 2 | 2023 | 1938 | 0.610 |
Why?
|
Reproduction | 2 | 2012 | 668 | 0.600 |
Why?
|
Energy Intake | 7 | 2023 | 2148 | 0.600 |
Why?
|
Vitamin K | 1 | 2019 | 295 | 0.580 |
Why?
|
Infant, Premature, Diseases | 6 | 2019 | 706 | 0.580 |
Why?
|
Hypoglycemia | 2 | 2016 | 861 | 0.570 |
Why?
|
Hepatic Insufficiency | 1 | 2016 | 13 | 0.550 |
Why?
|
Mucolipidoses | 2 | 2019 | 82 | 0.550 |
Why?
|
Hepatectomy | 8 | 2011 | 550 | 0.550 |
Why?
|
Digestive System Diseases | 1 | 2017 | 147 | 0.540 |
Why?
|
Plant Oils | 6 | 2016 | 202 | 0.540 |
Why?
|
Nutritional Requirements | 2 | 2017 | 286 | 0.540 |
Why?
|
Lipid Metabolism | 5 | 2022 | 1889 | 0.530 |
Why?
|
Pruritus | 1 | 2019 | 361 | 0.530 |
Why?
|
Humans | 122 | 2024 | 744343 | 0.530 |
Why?
|
Perioperative Care | 3 | 2017 | 1002 | 0.520 |
Why?
|
Organ Size | 6 | 2020 | 2252 | 0.520 |
Why?
|
Alkaline Phosphatase | 2 | 2017 | 865 | 0.510 |
Why?
|
Femur | 2 | 2018 | 1297 | 0.490 |
Why?
|
Uterus | 4 | 2012 | 711 | 0.480 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2012 | 341 | 0.480 |
Why?
|
Infant, Low Birth Weight | 3 | 2012 | 850 | 0.460 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2019 | 4420 | 0.460 |
Why?
|
PPAR alpha | 2 | 2023 | 197 | 0.450 |
Why?
|
Bone Diseases, Metabolic | 2 | 2014 | 417 | 0.450 |
Why?
|
Benzofurans | 1 | 2014 | 140 | 0.450 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2014 | 226 | 0.450 |
Why?
|
Insulin Resistance | 4 | 2022 | 3864 | 0.450 |
Why?
|
Eicosapentaenoic Acid | 6 | 2017 | 582 | 0.450 |
Why?
|
Awards and Prizes | 1 | 2017 | 375 | 0.440 |
Why?
|
Infant, Premature | 5 | 2013 | 2044 | 0.430 |
Why?
|
Diet | 9 | 2024 | 7939 | 0.430 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2016 | 1130 | 0.430 |
Why?
|
Specialties, Surgical | 1 | 2017 | 391 | 0.430 |
Why?
|
Neuroblastoma | 2 | 2011 | 1226 | 0.420 |
Why?
|
Liver Function Tests | 5 | 2014 | 528 | 0.410 |
Why?
|
Models, Biological | 2 | 2020 | 9583 | 0.410 |
Why?
|
Gastroschisis | 1 | 2012 | 97 | 0.400 |
Why?
|
Genetic Fitness | 1 | 2012 | 121 | 0.400 |
Why?
|
Postoperative Care | 1 | 2018 | 1486 | 0.400 |
Why?
|
Matrix Metalloproteinase 2 | 3 | 2010 | 472 | 0.390 |
Why?
|
Liver Transplantation | 6 | 2020 | 2119 | 0.390 |
Why?
|
Sulfones | 1 | 2014 | 437 | 0.390 |
Why?
|
Neovascularization, Physiologic | 6 | 2018 | 1351 | 0.390 |
Why?
|
Child, Preschool | 18 | 2020 | 41006 | 0.390 |
Why?
|
Anti-Bacterial Agents | 5 | 2020 | 7181 | 0.390 |
Why?
|
Lipid Regulating Agents | 1 | 2010 | 24 | 0.380 |
Why?
|
Bone Development | 1 | 2014 | 483 | 0.380 |
Why?
|
Cell Proliferation | 9 | 2024 | 10481 | 0.370 |
Why?
|
Female | 56 | 2024 | 380194 | 0.370 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 561 | 0.370 |
Why?
|
Hirudins | 2 | 2023 | 183 | 0.370 |
Why?
|
Wound Healing | 4 | 2018 | 2785 | 0.370 |
Why?
|
Retrospective Studies | 22 | 2023 | 77449 | 0.370 |
Why?
|
Matrix Metalloproteinase 9 | 3 | 2010 | 638 | 0.370 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2010 | 66 | 0.360 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2012 | 546 | 0.360 |
Why?
|
ADAM Proteins | 1 | 2011 | 243 | 0.360 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3772 | 0.360 |
Why?
|
Child | 22 | 2023 | 77709 | 0.360 |
Why?
|
Postoperative Complications | 6 | 2023 | 15295 | 0.360 |
Why?
|
Health | 1 | 2012 | 394 | 0.350 |
Why?
|
Weight Gain | 7 | 2018 | 2292 | 0.340 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2008 | 51 | 0.340 |
Why?
|
Colon | 4 | 2013 | 1772 | 0.330 |
Why?
|
Phytosterols | 3 | 2019 | 64 | 0.330 |
Why?
|
Hepatocytes | 4 | 2019 | 1211 | 0.330 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2020 | 10943 | 0.330 |
Why?
|
Laparotomy | 1 | 2011 | 473 | 0.320 |
Why?
|
Rabbits | 5 | 2013 | 4894 | 0.320 |
Why?
|
Acetaminophen | 1 | 2012 | 545 | 0.320 |
Why?
|
Necrosis | 4 | 2019 | 1643 | 0.310 |
Why?
|
Treatment Outcome | 20 | 2023 | 63114 | 0.310 |
Why?
|
Intestinal Absorption | 4 | 2024 | 420 | 0.310 |
Why?
|
Leptin | 3 | 2011 | 1599 | 0.300 |
Why?
|
Oocytes | 1 | 2012 | 1187 | 0.300 |
Why?
|
Dyslipidemias | 2 | 2015 | 849 | 0.300 |
Why?
|
Growth Disorders | 1 | 2012 | 645 | 0.300 |
Why?
|
Protein Kinase Inhibitors | 3 | 2012 | 5535 | 0.300 |
Why?
|
Biliary Tract | 1 | 2008 | 134 | 0.290 |
Why?
|
Blood Glucose | 3 | 2019 | 6256 | 0.290 |
Why?
|
Ribs | 1 | 2008 | 252 | 0.290 |
Why?
|
Hepatitis | 1 | 2008 | 227 | 0.290 |
Why?
|
Inflammation | 6 | 2024 | 10638 | 0.280 |
Why?
|
Animals, Newborn | 3 | 2023 | 2726 | 0.280 |
Why?
|
Serum Albumin | 1 | 2009 | 676 | 0.280 |
Why?
|
Nutritional Support | 2 | 2022 | 168 | 0.280 |
Why?
|
Bone and Bones | 2 | 2014 | 2575 | 0.280 |
Why?
|
Recombinant Proteins | 3 | 2023 | 6622 | 0.280 |
Why?
|
Metabolome | 1 | 2013 | 895 | 0.280 |
Why?
|
Blood Vessels | 2 | 2015 | 1125 | 0.270 |
Why?
|
Hypertriglyceridemia | 2 | 2017 | 293 | 0.270 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 3610 | 0.270 |
Why?
|
Deficiency Diseases | 2 | 2017 | 72 | 0.270 |
Why?
|
Dietary Carbohydrates | 2 | 2012 | 906 | 0.270 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2014 | 2282 | 0.270 |
Why?
|
Iatrogenic Disease | 1 | 2009 | 547 | 0.270 |
Why?
|
Aluminum | 1 | 2006 | 152 | 0.260 |
Why?
|
Critical Illness | 5 | 2022 | 2670 | 0.260 |
Why?
|
Cholecystitis, Acute | 1 | 2006 | 70 | 0.260 |
Why?
|
Microvilli | 2 | 2019 | 241 | 0.260 |
Why?
|
Nutritional Status | 4 | 2022 | 1609 | 0.260 |
Why?
|
Hyperlipidemias | 1 | 2010 | 789 | 0.260 |
Why?
|
Intestinal Obstruction | 2 | 2008 | 424 | 0.260 |
Why?
|
Bone Density | 2 | 2018 | 3468 | 0.260 |
Why?
|
Respiratory Function Tests | 2 | 2020 | 1616 | 0.260 |
Why?
|
Ceftriaxone | 1 | 2006 | 168 | 0.260 |
Why?
|
Drug Contamination | 1 | 2006 | 147 | 0.250 |
Why?
|
Stearoyl-CoA Desaturase | 2 | 2019 | 86 | 0.250 |
Why?
|
Aspartate Aminotransferases | 3 | 2020 | 418 | 0.250 |
Why?
|
Bone Diseases | 1 | 2008 | 416 | 0.250 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1889 | 0.250 |
Why?
|
Metabolomics | 1 | 2013 | 1484 | 0.240 |
Why?
|
Cholelithiasis | 1 | 2006 | 414 | 0.240 |
Why?
|
C-Reactive Protein | 7 | 2020 | 3778 | 0.240 |
Why?
|
Signal Transduction | 10 | 2021 | 23403 | 0.240 |
Why?
|
Administration, Oral | 4 | 2013 | 3913 | 0.240 |
Why?
|
Wounds, Penetrating | 1 | 2006 | 307 | 0.240 |
Why?
|
Gestational Age | 4 | 2014 | 3493 | 0.230 |
Why?
|
Random Allocation | 4 | 2017 | 2429 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5751 | 0.230 |
Why?
|
Thymoma | 1 | 2005 | 186 | 0.230 |
Why?
|
Body Weight | 6 | 2018 | 4669 | 0.230 |
Why?
|
Vitamins | 2 | 2022 | 1622 | 0.230 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 371 | 0.230 |
Why?
|
Length of Stay | 4 | 2020 | 6309 | 0.220 |
Why?
|
Bile Acids and Salts | 2 | 2023 | 367 | 0.220 |
Why?
|
Poland Syndrome | 1 | 2002 | 14 | 0.220 |
Why?
|
Hyperglycemia | 1 | 2011 | 1373 | 0.220 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 286 | 0.220 |
Why?
|
Fetal Diseases | 1 | 2008 | 903 | 0.220 |
Why?
|
Thymus Neoplasms | 1 | 2005 | 268 | 0.220 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2018 | 1375 | 0.210 |
Why?
|
Sepsis | 4 | 2021 | 2593 | 0.210 |
Why?
|
Hypertension, Pulmonary | 2 | 2023 | 1537 | 0.210 |
Why?
|
Gastrointestinal Diseases | 3 | 2019 | 1170 | 0.210 |
Why?
|
Mice, Knockout | 5 | 2021 | 14557 | 0.210 |
Why?
|
Foreign Bodies | 1 | 2006 | 399 | 0.210 |
Why?
|
Microcirculation | 3 | 2021 | 1286 | 0.210 |
Why?
|
Fractures, Bone | 1 | 2014 | 1947 | 0.210 |
Why?
|
Regeneration | 5 | 2018 | 1485 | 0.200 |
Why?
|
Biomedical Research | 1 | 2017 | 3309 | 0.200 |
Why?
|
Statistics, Nonparametric | 4 | 2009 | 2886 | 0.200 |
Why?
|
Birth Weight | 3 | 2016 | 2069 | 0.200 |
Why?
|
Carbohydrates | 1 | 2023 | 394 | 0.200 |
Why?
|
Rectum | 1 | 2006 | 904 | 0.200 |
Why?
|
Eicosanoids | 2 | 2013 | 279 | 0.200 |
Why?
|
Swine, Miniature | 1 | 2023 | 961 | 0.200 |
Why?
|
Spinal Neoplasms | 1 | 2008 | 760 | 0.200 |
Why?
|
Thrombin | 1 | 2023 | 598 | 0.190 |
Why?
|
Prenatal Diagnosis | 1 | 2008 | 1236 | 0.190 |
Why?
|
Compliance | 1 | 2020 | 104 | 0.190 |
Why?
|
Serum Sickness | 1 | 2020 | 28 | 0.190 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2022 | 339 | 0.190 |
Why?
|
Living Donors | 1 | 2005 | 620 | 0.190 |
Why?
|
Pancreatic Elastase | 1 | 2020 | 136 | 0.190 |
Why?
|
Total Lung Capacity | 1 | 2020 | 143 | 0.180 |
Why?
|
Picolinic Acids | 1 | 2020 | 53 | 0.180 |
Why?
|
Rats | 13 | 2023 | 24260 | 0.180 |
Why?
|
Case-Control Studies | 4 | 2020 | 21746 | 0.180 |
Why?
|
Urinary Bladder | 1 | 2006 | 1172 | 0.180 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 340 | 0.180 |
Why?
|
Membrane Lipids | 2 | 2013 | 248 | 0.180 |
Why?
|
Down-Regulation | 2 | 2022 | 3002 | 0.180 |
Why?
|
Probability | 3 | 2014 | 2505 | 0.180 |
Why?
|
Vomiting | 1 | 2023 | 636 | 0.180 |
Why?
|
Ribosomal Proteins | 4 | 1995 | 360 | 0.180 |
Why?
|
Hematocrit | 1 | 2021 | 636 | 0.180 |
Why?
|
alpha-Linolenic Acid | 2 | 2017 | 144 | 0.170 |
Why?
|
Diet, Fat-Restricted | 2 | 2012 | 320 | 0.170 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 841 | 0.170 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2019 | 107 | 0.170 |
Why?
|
Product Labeling | 1 | 2019 | 79 | 0.170 |
Why?
|
Peptide Fragments | 2 | 2023 | 5097 | 0.160 |
Why?
|
Time Factors | 7 | 2020 | 40075 | 0.160 |
Why?
|
Incidence | 4 | 2022 | 20947 | 0.160 |
Why?
|
Surface-Active Agents | 1 | 2018 | 159 | 0.160 |
Why?
|
Eczema | 1 | 2020 | 231 | 0.160 |
Why?
|
Anticoagulants | 2 | 2023 | 4599 | 0.150 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 426 | 0.150 |
Why?
|
Half-Life | 1 | 2018 | 661 | 0.150 |
Why?
|
International Normalized Ratio | 1 | 2019 | 367 | 0.150 |
Why?
|
gamma-Glutamyltransferase | 1 | 2017 | 134 | 0.150 |
Why?
|
Anti-Inflammatory Agents | 2 | 2019 | 1790 | 0.150 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1997 | 79 | 0.150 |
Why?
|
Infant Nutrition Disorders | 1 | 2017 | 73 | 0.150 |
Why?
|
Microvessels | 2 | 2011 | 544 | 0.150 |
Why?
|
Micronutrients | 2 | 2017 | 375 | 0.150 |
Why?
|
Administration, Intranasal | 1 | 2018 | 446 | 0.140 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 2 | 2010 | 137 | 0.140 |
Why?
|
Salicylates | 1 | 1997 | 126 | 0.140 |
Why?
|
Leukotriene C4 | 1 | 1997 | 97 | 0.140 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 362 | 0.140 |
Why?
|
Insulin | 1 | 2011 | 6580 | 0.140 |
Why?
|
Sesquiterpenes | 4 | 2005 | 177 | 0.140 |
Why?
|
Choroidal Neovascularization | 1 | 2020 | 343 | 0.140 |
Why?
|
Endothelium, Vascular | 3 | 2015 | 4456 | 0.140 |
Why?
|
Obesity | 3 | 2022 | 12745 | 0.140 |
Why?
|
Severity of Illness Index | 5 | 2016 | 15540 | 0.140 |
Why?
|
Organogenesis | 1 | 2018 | 222 | 0.140 |
Why?
|
Ethanol | 1 | 2023 | 1342 | 0.140 |
Why?
|
Abdominal Pain | 1 | 2023 | 1063 | 0.140 |
Why?
|
Hyperbilirubinemia | 1 | 2016 | 77 | 0.140 |
Why?
|
Fibrosis | 1 | 2023 | 2029 | 0.140 |
Why?
|
Ileum | 2 | 2017 | 565 | 0.140 |
Why?
|
Safflower Oil | 1 | 2015 | 29 | 0.140 |
Why?
|
Prospective Studies | 6 | 2021 | 53288 | 0.140 |
Why?
|
Child Nutrition Disorders | 1 | 2017 | 149 | 0.140 |
Why?
|
Hyperoxia | 1 | 2018 | 262 | 0.130 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 809 | 0.130 |
Why?
|
Peptides | 3 | 2023 | 4409 | 0.130 |
Why?
|
Drug Design | 1 | 2021 | 1076 | 0.130 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2017 | 303 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 552 | 0.130 |
Why?
|
Kidney | 2 | 2013 | 7186 | 0.130 |
Why?
|
DNA, Complementary | 4 | 1996 | 2050 | 0.130 |
Why?
|
Biometry | 1 | 2018 | 558 | 0.130 |
Why?
|
Epidermal Growth Factor | 1 | 2018 | 708 | 0.130 |
Why?
|
Pulmonary Emphysema | 1 | 2020 | 672 | 0.130 |
Why?
|
Shock, Septic | 1 | 2021 | 775 | 0.130 |
Why?
|
Pyrazoles | 1 | 2005 | 1972 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 3557 | 0.120 |
Why?
|
Postprandial Period | 1 | 2016 | 292 | 0.120 |
Why?
|
Risk Factors | 10 | 2018 | 72290 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 9959 | 0.120 |
Why?
|
Glutathione | 1 | 1997 | 589 | 0.120 |
Why?
|
Phenotype | 4 | 2010 | 16365 | 0.120 |
Why?
|
Wnt Proteins | 2 | 2009 | 721 | 0.120 |
Why?
|
Cesarean Section | 1 | 2023 | 1365 | 0.120 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2018 | 306 | 0.120 |
Why?
|
Pulmonary Ventilation | 1 | 2016 | 373 | 0.120 |
Why?
|
Vision Disorders | 1 | 2021 | 1058 | 0.120 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2158 | 0.120 |
Why?
|
Immunoenzyme Techniques | 2 | 2007 | 1799 | 0.120 |
Why?
|
Hospitals, Pediatric | 2 | 2016 | 1775 | 0.120 |
Why?
|
Wounds and Injuries | 3 | 2013 | 2400 | 0.120 |
Why?
|
Aging | 1 | 2012 | 8664 | 0.110 |
Why?
|
Exercise Test | 1 | 2021 | 2074 | 0.110 |
Why?
|
Protein Folding | 1 | 1997 | 843 | 0.110 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 654 | 0.110 |
Why?
|
Fever | 2 | 2018 | 1616 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2021 | 1881 | 0.110 |
Why?
|
Heart Diseases | 1 | 2006 | 2788 | 0.110 |
Why?
|
Remission Induction | 1 | 2019 | 2386 | 0.110 |
Why?
|
Breeding | 1 | 2012 | 51 | 0.110 |
Why?
|
Litter Size | 1 | 2012 | 54 | 0.110 |
Why?
|
Child Development | 2 | 2016 | 2223 | 0.110 |
Why?
|
Epoxy Compounds | 1 | 2013 | 136 | 0.110 |
Why?
|
Endpoint Determination | 1 | 2016 | 601 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1114 | 0.110 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2019 | 780 | 0.110 |
Why?
|
Abdominal Wound Closure Techniques | 1 | 2012 | 33 | 0.110 |
Why?
|
Research Personnel | 1 | 2017 | 573 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 1 | 2020 | 1035 | 0.100 |
Why?
|
Lipid Peroxidation | 1 | 2013 | 270 | 0.100 |
Why?
|
Pneumonia | 1 | 2024 | 2133 | 0.100 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2011 | 34 | 0.100 |
Why?
|
X-Ray Microtomography | 1 | 2014 | 428 | 0.100 |
Why?
|
Oxidative Stress | 2 | 2013 | 3086 | 0.100 |
Why?
|
Mice, SCID | 4 | 2011 | 2716 | 0.100 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2274 | 0.100 |
Why?
|
Biopsy, Needle | 2 | 2008 | 1641 | 0.100 |
Why?
|
Diarrhea, Infantile | 1 | 2011 | 109 | 0.100 |
Why?
|
History, 21st Century | 1 | 2017 | 1534 | 0.100 |
Why?
|
Up-Regulation | 1 | 2020 | 4217 | 0.100 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1420 | 0.100 |
Why?
|
Cholesterol | 2 | 2010 | 2917 | 0.100 |
Why?
|
Solutions | 1 | 2011 | 426 | 0.100 |
Why?
|
Boston | 3 | 2016 | 9313 | 0.100 |
Why?
|
Electrolytes | 1 | 2011 | 282 | 0.100 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 402 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2015 | 1588 | 0.100 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1912 | 0.090 |
Why?
|
Arthritis, Rheumatoid | 1 | 2006 | 3712 | 0.090 |
Why?
|
Carbon Tetrachloride | 1 | 2010 | 64 | 0.090 |
Why?
|
Pregnancy | 5 | 2023 | 29144 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8642 | 0.090 |
Why?
|
Inclusion Bodies | 1 | 2011 | 279 | 0.090 |
Why?
|
Brain Concussion | 1 | 2021 | 1320 | 0.090 |
Why?
|
Tensile Strength | 1 | 2011 | 335 | 0.090 |
Why?
|
Spleen | 1 | 2016 | 2362 | 0.090 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 987 | 0.090 |
Why?
|
Anthropometry | 1 | 2015 | 1350 | 0.090 |
Why?
|
Adipogenesis | 1 | 2012 | 359 | 0.090 |
Why?
|
Cell Survival | 2 | 2018 | 5882 | 0.090 |
Why?
|
Colostomy | 2 | 2008 | 99 | 0.090 |
Why?
|
Malnutrition | 1 | 2016 | 625 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 3760 | 0.090 |
Why?
|
Phosphorylation | 2 | 2020 | 8436 | 0.090 |
Why?
|
Eating | 3 | 2012 | 1536 | 0.090 |
Why?
|
Bone Remodeling | 1 | 2013 | 575 | 0.090 |
Why?
|
Hyperphagia | 1 | 2010 | 136 | 0.090 |
Why?
|
Milk | 1 | 2012 | 450 | 0.090 |
Why?
|
Reference Values | 2 | 2008 | 4982 | 0.090 |
Why?
|
Adipokines | 1 | 2011 | 319 | 0.080 |
Why?
|
Glutamine | 1 | 2012 | 578 | 0.080 |
Why?
|
Placebos | 1 | 2013 | 1676 | 0.080 |
Why?
|
Endotoxins | 1 | 2011 | 527 | 0.080 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2012 | 365 | 0.080 |
Why?
|
Feedback, Physiological | 1 | 2011 | 479 | 0.080 |
Why?
|
Fetal Movement | 1 | 2008 | 21 | 0.080 |
Why?
|
Disease Progression | 2 | 2016 | 13284 | 0.080 |
Why?
|
Luteolysis | 1 | 2008 | 11 | 0.080 |
Why?
|
Animal Feed | 1 | 2008 | 110 | 0.080 |
Why?
|
Glucose | 2 | 2011 | 4397 | 0.080 |
Why?
|
Apoptosis | 6 | 2020 | 9727 | 0.080 |
Why?
|
Probiotics | 1 | 2012 | 351 | 0.080 |
Why?
|
Common Bile Duct | 1 | 2008 | 109 | 0.080 |
Why?
|
Osteochondroma | 1 | 2008 | 47 | 0.080 |
Why?
|
Biliary Atresia | 1 | 2008 | 73 | 0.080 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2008 | 62 | 0.080 |
Why?
|
Capillaries | 3 | 2008 | 773 | 0.080 |
Why?
|
Osteoblasts | 1 | 2014 | 1166 | 0.080 |
Why?
|
Corpus Luteum | 1 | 2008 | 86 | 0.080 |
Why?
|
Stress, Mechanical | 1 | 2013 | 1686 | 0.080 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2008 | 73 | 0.080 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 216 | 0.080 |
Why?
|
Adolescent | 6 | 2019 | 85781 | 0.080 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2008 | 91 | 0.080 |
Why?
|
Hypothalamus | 3 | 1985 | 1063 | 0.080 |
Why?
|
Mice, Transgenic | 5 | 2015 | 9734 | 0.080 |
Why?
|
Hernia, Abdominal | 1 | 2008 | 53 | 0.080 |
Why?
|
Ligation | 1 | 2008 | 453 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2029 | 0.080 |
Why?
|
Survival Rate | 2 | 2014 | 12788 | 0.080 |
Why?
|
Milk, Human | 1 | 2012 | 490 | 0.080 |
Why?
|
Germany | 1 | 2009 | 862 | 0.080 |
Why?
|
Mesentery | 1 | 2008 | 205 | 0.070 |
Why?
|
Abdominal Cavity | 1 | 2007 | 52 | 0.070 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2008 | 188 | 0.070 |
Why?
|
Food, Fortified | 1 | 2008 | 191 | 0.070 |
Why?
|
Cell Line, Tumor | 3 | 2014 | 16689 | 0.070 |
Why?
|
Drug Evaluation | 1 | 2008 | 647 | 0.070 |
Why?
|
Retina | 2 | 2021 | 2616 | 0.070 |
Why?
|
Zebrafish | 2 | 2009 | 2994 | 0.070 |
Why?
|
Escherichia coli | 1 | 2019 | 4217 | 0.070 |
Why?
|
Cell Membrane | 2 | 2012 | 3748 | 0.070 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 2006 | 599 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2015 | 1018 | 0.070 |
Why?
|
Adult | 8 | 2023 | 214055 | 0.070 |
Why?
|
Priapism | 1 | 2006 | 31 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9648 | 0.070 |
Why?
|
Hepatocyte Growth Factor | 1 | 2008 | 270 | 0.070 |
Why?
|
Mental Disorders | 1 | 2006 | 6600 | 0.070 |
Why?
|
Neovascularization, Pathologic | 3 | 2007 | 2635 | 0.070 |
Why?
|
Afferent Pathways | 2 | 1985 | 302 | 0.070 |
Why?
|
United States | 5 | 2017 | 69872 | 0.070 |
Why?
|
Neutrophils | 3 | 2015 | 3719 | 0.070 |
Why?
|
Spinal Cord Compression | 1 | 2008 | 235 | 0.070 |
Why?
|
Cystoscopy | 1 | 2006 | 134 | 0.070 |
Why?
|
Dinoprostone | 1 | 2009 | 600 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12245 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2007 | 776 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2014 | 941 | 0.070 |
Why?
|
Chondrosarcoma | 1 | 2008 | 309 | 0.070 |
Why?
|
Recurrence | 2 | 2021 | 8340 | 0.070 |
Why?
|
Tumor Burden | 1 | 2011 | 1915 | 0.070 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2007 | 772 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 357 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 12072 | 0.070 |
Why?
|
Consumer Product Safety | 1 | 2006 | 122 | 0.070 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 643 | 0.070 |
Why?
|
Amino Acids | 1 | 2011 | 1736 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1782 | 0.060 |
Why?
|
Antioxidants | 1 | 2013 | 1663 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1405 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2004 | 68 | 0.060 |
Why?
|
Erythrocyte Membrane | 2 | 2015 | 442 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2647 | 0.060 |
Why?
|
Bone Marrow Transplantation | 3 | 2007 | 2765 | 0.060 |
Why?
|
Blotting, Western | 2 | 2010 | 5179 | 0.060 |
Why?
|
Creatinine | 1 | 2010 | 1919 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 149 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2618 | 0.060 |
Why?
|
RNA, Messenger | 5 | 2011 | 13033 | 0.060 |
Why?
|
Transcription Factors | 1 | 2004 | 12208 | 0.060 |
Why?
|
Endothelial Growth Factors | 1 | 2006 | 694 | 0.060 |
Why?
|
Embryonic Development | 1 | 2009 | 711 | 0.060 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2006 | 230 | 0.060 |
Why?
|
Cyclohexanes | 4 | 2005 | 152 | 0.060 |
Why?
|
Fasting | 1 | 2010 | 1593 | 0.060 |
Why?
|
Methacrylates | 1 | 2004 | 107 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 1814 | 0.060 |
Why?
|
Progesterone | 1 | 2008 | 776 | 0.060 |
Why?
|
Premature Birth | 1 | 2016 | 1721 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2006 | 391 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1660 | 0.060 |
Why?
|
Breast Feeding | 1 | 2011 | 1338 | 0.060 |
Why?
|
Prognosis | 2 | 2016 | 29063 | 0.060 |
Why?
|
Luteinizing Hormone | 3 | 1985 | 869 | 0.060 |
Why?
|
Mice, Obese | 1 | 2004 | 424 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4776 | 0.060 |
Why?
|
Models, Educational | 1 | 2006 | 377 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2008 | 881 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.050 |
Why?
|
Radiography | 2 | 2005 | 7023 | 0.050 |
Why?
|
Computer-Assisted Instruction | 1 | 2006 | 365 | 0.050 |
Why?
|
Chronic Disease | 2 | 2016 | 9146 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7659 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2010 | 1403 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 2 | 2008 | 1695 | 0.050 |
Why?
|
Stem Cells | 2 | 2013 | 3567 | 0.050 |
Why?
|
Fresh Water | 1 | 2002 | 83 | 0.050 |
Why?
|
Twins, Conjoined | 1 | 2002 | 41 | 0.050 |
Why?
|
Sex Offenses | 1 | 2006 | 354 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2538 | 0.050 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2012 | 2795 | 0.050 |
Why?
|
Immunohistochemistry | 5 | 2013 | 11366 | 0.050 |
Why?
|
Seawater | 1 | 2002 | 121 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8324 | 0.050 |
Why?
|
Capillary Permeability | 1 | 2005 | 798 | 0.050 |
Why?
|
Delivery, Obstetric | 1 | 2008 | 906 | 0.050 |
Why?
|
Corticosterone | 1 | 1982 | 310 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2356 | 0.050 |
Why?
|
Risk Assessment | 3 | 2019 | 23338 | 0.050 |
Why?
|
Cognition | 2 | 2021 | 6770 | 0.050 |
Why?
|
Pericytes | 1 | 2023 | 292 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2024 | 1147 | 0.050 |
Why?
|
Stromal Cells | 1 | 2006 | 1355 | 0.050 |
Why?
|
Adiposity | 1 | 2010 | 1807 | 0.050 |
Why?
|
Optic Nerve Injuries | 1 | 2021 | 150 | 0.050 |
Why?
|
Acute Disease | 1 | 2011 | 7149 | 0.050 |
Why?
|
Heart | 1 | 2013 | 4467 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2012 | 8301 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3870 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2023 | 634 | 0.040 |
Why?
|
Conditioning, Operant | 1 | 2021 | 313 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1982 | 648 | 0.040 |
Why?
|
Electroretinography | 1 | 2021 | 509 | 0.040 |
Why?
|
Computer Simulation | 2 | 2020 | 6196 | 0.040 |
Why?
|
Societies, Medical | 1 | 2011 | 3743 | 0.040 |
Why?
|
Maze Learning | 1 | 2021 | 478 | 0.040 |
Why?
|
Recovery of Function | 1 | 2010 | 2925 | 0.040 |
Why?
|
Endometriosis | 1 | 2007 | 839 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.040 |
Why?
|
Massachusetts | 2 | 2009 | 8663 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 2020 | 964 | 0.040 |
Why?
|
Biopsy | 2 | 2008 | 6756 | 0.040 |
Why?
|
Glycoproteins | 1 | 2007 | 2263 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2013 | 12026 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2021 | 427 | 0.040 |
Why?
|
Smoke | 1 | 2020 | 227 | 0.040 |
Why?
|
Mitochondria | 1 | 2011 | 3520 | 0.040 |
Why?
|
Cohort Studies | 3 | 2017 | 40561 | 0.040 |
Why?
|
Colonoscopy | 1 | 2006 | 1367 | 0.040 |
Why?
|
United States Food and Drug Administration | 1 | 2006 | 1584 | 0.040 |
Why?
|
Thoracic Surgical Procedures | 1 | 2002 | 342 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 2513 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1143 | 0.040 |
Why?
|
Ecosystem | 1 | 2002 | 474 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7279 | 0.040 |
Why?
|
Molecular Structure | 2 | 2004 | 1899 | 0.040 |
Why?
|
Affinity Labels | 1 | 1997 | 109 | 0.040 |
Why?
|
Young Adult | 2 | 2017 | 56430 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39050 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6538 | 0.040 |
Why?
|
Visual Pathways | 1 | 2021 | 565 | 0.040 |
Why?
|
Therapeutic Equivalency | 1 | 2017 | 141 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3798 | 0.040 |
Why?
|
Cytokines | 2 | 2023 | 7322 | 0.040 |
Why?
|
Antigens, CD | 1 | 2007 | 4026 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2007 | 5974 | 0.040 |
Why?
|
HL-60 Cells | 1 | 1997 | 365 | 0.040 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2019 | 406 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2009 | 3386 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2529 | 0.030 |
Why?
|
Micelles | 1 | 2017 | 203 | 0.030 |
Why?
|
Environment | 1 | 2002 | 1124 | 0.030 |
Why?
|
Platelet Count | 1 | 2018 | 781 | 0.030 |
Why?
|
Stomach Neoplasms | 2 | 1995 | 1333 | 0.030 |
Why?
|
Prodrugs | 1 | 2017 | 268 | 0.030 |
Why?
|
Mixed Function Oxygenases | 1 | 1996 | 272 | 0.030 |
Why?
|
Analgesics | 1 | 1982 | 1040 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 1997 | 13815 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10252 | 0.030 |
Why?
|
Vitamin E | 1 | 2019 | 869 | 0.030 |
Why?
|
Deoxyadenine Nucleotides | 1 | 1994 | 12 | 0.030 |
Why?
|
Phosphorus Radioisotopes | 1 | 1994 | 104 | 0.030 |
Why?
|
General Surgery | 1 | 2006 | 1636 | 0.030 |
Why?
|
Colonic Neoplasms | 3 | 1995 | 2541 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2017 | 723 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13989 | 0.030 |
Why?
|
RNA, Neoplasm | 2 | 1994 | 769 | 0.030 |
Why?
|
Ubiquitins | 1 | 1995 | 384 | 0.030 |
Why?
|
Education, Medical | 1 | 2006 | 1721 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1996 | 419 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2008 | 11031 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 314 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 1997 | 1032 | 0.030 |
Why?
|
Sequence Analysis | 1 | 1994 | 256 | 0.030 |
Why?
|
beta Catenin | 2 | 2009 | 1059 | 0.030 |
Why?
|
NAD | 1 | 1997 | 593 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12959 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2021 | 1901 | 0.030 |
Why?
|
Receptor, TIE-2 | 1 | 2013 | 178 | 0.030 |
Why?
|
Epoxide Hydrolases | 1 | 2013 | 122 | 0.030 |
Why?
|
Visual Acuity | 1 | 2021 | 2530 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1993 | 1085 | 0.030 |
Why?
|
Hypolipidemic Agents | 1 | 2017 | 604 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3843 | 0.030 |
Why?
|
Sucrase | 1 | 2011 | 54 | 0.030 |
Why?
|
Learning | 1 | 2021 | 1713 | 0.030 |
Why?
|
Memory | 1 | 2021 | 2174 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2002 | 2266 | 0.020 |
Why?
|
Temperature | 1 | 2018 | 2206 | 0.020 |
Why?
|
Protein Precursors | 1 | 1995 | 1154 | 0.020 |
Why?
|
NF-kappa B | 1 | 2020 | 2499 | 0.020 |
Why?
|
Green Fluorescent Proteins | 2 | 2007 | 2088 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2008 | 35421 | 0.020 |
Why?
|
Gene Library | 1 | 1993 | 1074 | 0.020 |
Why?
|
Polymerase Chain Reaction | 3 | 1996 | 6171 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 1997 | 2025 | 0.020 |
Why?
|
Base Sequence | 4 | 1995 | 12797 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4320 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14722 | 0.020 |
Why?
|
Echocardiography | 1 | 2002 | 5102 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 976 | 0.020 |
Why?
|
Kinetics | 1 | 1997 | 6473 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5655 | 0.020 |
Why?
|
Eye | 1 | 2013 | 729 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 1995 | 18111 | 0.020 |
Why?
|
Blotting, Northern | 3 | 1995 | 1581 | 0.020 |
Why?
|
Microspheres | 1 | 2011 | 777 | 0.020 |
Why?
|
Lipogenesis | 1 | 2010 | 212 | 0.020 |
Why?
|
Binding Sites | 1 | 1997 | 6114 | 0.020 |
Why?
|
Dinoprost | 1 | 2008 | 138 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2011 | 968 | 0.020 |
Why?
|
Colon, Sigmoid | 1 | 2008 | 120 | 0.020 |
Why?
|
Duodenal Diseases | 1 | 2008 | 102 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11524 | 0.020 |
Why?
|
Endoderm | 1 | 2008 | 154 | 0.020 |
Why?
|
Caloric Restriction | 1 | 2010 | 302 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 264 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1157 | 0.020 |
Why?
|
Ceramides | 1 | 2008 | 199 | 0.020 |
Why?
|
Gene Expression | 3 | 1995 | 7799 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15076 | 0.020 |
Why?
|
Brain | 1 | 2012 | 26385 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2008 | 595 | 0.020 |
Why?
|
Angiostatins | 1 | 2005 | 67 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2002 | 4584 | 0.020 |
Why?
|
Middle Aged | 2 | 2017 | 213383 | 0.020 |
Why?
|
Castration | 1 | 1985 | 159 | 0.020 |
Why?
|
Antigens, Ly | 1 | 2006 | 291 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2008 | 895 | 0.020 |
Why?
|
Prolactin | 2 | 1985 | 669 | 0.020 |
Why?
|
Electrophoresis | 1 | 2004 | 240 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 1312 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 2005 | 484 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2017 | 3679 | 0.010 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2005 | 241 | 0.010 |
Why?
|
Body Patterning | 1 | 2008 | 626 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 29786 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 2186 | 0.010 |
Why?
|
Oxygen | 1 | 2015 | 4189 | 0.010 |
Why?
|
Water Pollution | 1 | 2002 | 32 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2003 | 285 | 0.010 |
Why?
|
Pulmonary Edema | 1 | 2005 | 414 | 0.010 |
Why?
|
Chick Embryo | 1 | 2004 | 982 | 0.010 |
Why?
|
Cell Count | 1 | 2006 | 1856 | 0.010 |
Why?
|
United States Environmental Protection Agency | 1 | 2002 | 139 | 0.010 |
Why?
|
Ovulation | 2 | 1980 | 189 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1294 | 0.010 |
Why?
|
Power Plants | 1 | 2002 | 119 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1993 | 2214 | 0.010 |
Why?
|
Neoplasms | 3 | 2006 | 21683 | 0.010 |
Why?
|
Fetofetal Transfusion | 1 | 2002 | 104 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13695 | 0.010 |
Why?
|
Safety | 1 | 2005 | 1186 | 0.010 |
Why?
|
DNA Primers | 2 | 1995 | 2892 | 0.010 |
Why?
|
Endothelium | 1 | 2003 | 778 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2005 | 1285 | 0.010 |
Why?
|
Needs Assessment | 1 | 2006 | 1147 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 1842 | 0.010 |
Why?
|
Vitamin D | 1 | 2013 | 3223 | 0.010 |
Why?
|
Cell Lineage | 1 | 2008 | 2504 | 0.010 |
Why?
|
Fishes | 1 | 2002 | 569 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10262 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2005 | 1904 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1993 | 4253 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2004 | 1017 | 0.010 |
Why?
|
Cannabinoids | 1 | 1980 | 166 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7913 | 0.010 |
Why?
|
Program Evaluation | 1 | 2006 | 2488 | 0.010 |
Why?
|
Polymers | 1 | 2004 | 1621 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4560 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11483 | 0.010 |
Why?
|
Thyroid Hormones | 1 | 1978 | 390 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6386 | 0.010 |
Why?
|
DNA Probes | 1 | 1995 | 560 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1978 | 1472 | 0.010 |
Why?
|
Threonine | 1 | 1994 | 279 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1993 | 6773 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2006 | 2291 | 0.010 |
Why?
|
Students, Medical | 1 | 2006 | 1862 | 0.010 |
Why?
|
Cell Movement | 1 | 2005 | 5217 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1977 | 703 | 0.010 |
Why?
|
Ovary | 1 | 1977 | 981 | 0.010 |
Why?
|
Carcinoma | 1 | 2004 | 2375 | 0.010 |
Why?
|
Zinc Fingers | 1 | 1994 | 585 | 0.010 |
Why?
|
Calcium | 1 | 2005 | 5756 | 0.010 |
Why?
|
Skin | 1 | 2005 | 4364 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1978 | 1173 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 12951 | 0.010 |
Why?
|
Serine | 1 | 1994 | 826 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1994 | 2839 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2006 | 7880 | 0.010 |
Why?
|
Plasmids | 1 | 1994 | 2307 | 0.010 |
Why?
|
Air Pollution | 1 | 2002 | 2286 | 0.010 |
Why?
|
Internship and Residency | 1 | 2006 | 5788 | 0.000 |
Why?
|
Melanoma | 1 | 2004 | 5510 | 0.000 |
Why?
|
Depression, Chemical | 1 | 1980 | 191 | 0.000 |
Why?
|
DNA | 1 | 1994 | 7301 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2004 | 13102 | 0.000 |
Why?
|
Haplorhini | 1 | 1980 | 552 | 0.000 |
Why?
|
Hydroxytryptophol | 1 | 1978 | 2 | 0.000 |
Why?
|
Pituitary Hormone-Releasing Hormones | 1 | 1977 | 41 | 0.000 |
Why?
|
Estrus | 1 | 1977 | 81 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1977 | 172 | 0.000 |
Why?
|
Triiodothyronine | 1 | 1978 | 494 | 0.000 |
Why?
|
Organ Culture Techniques | 1 | 1978 | 813 | 0.000 |
Why?
|
Follicle Stimulating Hormone | 1 | 1977 | 744 | 0.000 |
Why?
|
Thyroxine | 1 | 1978 | 667 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1980 | 3129 | 0.000 |
Why?
|
Serotonin | 1 | 1978 | 1017 | 0.000 |
Why?
|
Aged | 1 | 2006 | 163280 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1980 | 2375 | 0.000 |
Why?
|
Melatonin | 1 | 1978 | 721 | 0.000 |
Why?
|